Document Detail

Chk1 knockdown confers radiosensitization in prostate cancer stem cells.
MedLine Citation:
PMID:  23027394     Owner:  NLM     Status:  Publisher    
Radioresistance is responsible for treatment failure after radiotherapy in localized prostate cancer, while prostate cancer stem cells promote radioresistance by preferential activation of the DNA damage response. Chk1 inhibition has been shown to sensitize many tumor cells to radiation. However, whether Chk1 inhibition can potentiate the cytotoxic effects of radiation on prostate cancer stem cells remains to be elucidated. In this study, CD133+CD44+ cells were isolated using microbeads and were found to possess cancer stem cell properties. Using shRNA, Chk1 was knocked down in the sorted CD133+CD44+ cells. Our results demonstrated that Chk1 knockdown abrogated the radiation-induced G2/M arrest, inhibited DNA damage repair and promoted premature mitosis, leading to increased apoptosis in the radiated sorted CD133+CD44+ cells. Moreover, these effects were accompanied by caspase-2 activation and the inactivation of phosphorylated Cdc25C and Cdc2. Our results suggest that Chk1 knockdown increases the radiosensitivity of CD133+CD44+ prostate cancer stem cells. Chk1 knockdown in prostate cancer stem cells may be an effective therapeutic strategy against prostate cancer.
Xiaobin Wang; Zhikun Ma; Zheng Xiao; Hui Liu; Zhongling Dou; Xiaoshan Feng; Haijun Shi
Related Documents :
9746624 - Abdominal tuberculosis or ovarian carcinoma: management dilemma associated with an elev...
15578914 - Targeting apoptosis pathways in cancer therapy.
23039174 - Development and characterization of dexamethasone mesylate anchored on multi walled car...
21118094 - Revisiting the abcs of multidrug resistance in cancer chemotherapy.
22659694 - Bi-directional pcr allele-specific amplification (bi-pasa) for detection of caspase-8 -...
23565664 - Decreased expression of rna-binding motif protein 3 correlates with tumour progression ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-01
Journal Detail:
Title:  Oncology reports     Volume:  -     ISSN:  1791-2431     ISO Abbreviation:  Oncol. Rep.     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9422756     Medline TA:  Oncol Rep     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Urology, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang 471003, P.R. China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  [It's not Only the Gamblers who Need Help - A Pilot Study on a Family Training Programme].
Next Document:  Intracranial Aneurysm and Recessive Polycystic Kidney Disease: The Third Reported Case.